Business Alliance of MDV with TXP Medical Using Data to Evaluate New Drug Efficacy

TXP Medical Co. Ltd. (Chiyoda-ku, Tokyo; CEO: Dr. Tomohiro Sonoo), which aims to improve the quality and efficiency of emergency medicine through medical data and MEDICAL DATA VISION Co., Ltd. (Chiyoda-ku, Tokyo; President & CEO: Hiroyuki Iwasaki; hereinafter “MDV”), which owns one of the largest medical databases (DB) in Japan, have reached a basic agreement for the business alliance. TXP Medical’s DB of all medical care fields, including emergency medicine and MDV’s medical care DB, will be combined to support and accelerate data utilization by pharmaceutical companies, academia, and other organizations.

【Data of MDV】
MDV formed a business alliance with DeNA Inc. in May last year, and by linking the DBs accumulated by the two companies, MDV has built a more robust DB for insurers. The health insurance association data were added to the existing DB, and data on National Health Insurance subscribers and the elderly in the later stages of life were also added. As a result, the actual number of patients in the DB that can be utilized is 44.72 million (as of August 31, 2023) for MDV’s existing hospital data and 19.52 million (as of August 31, 2023) for insurers’ data.

【Data of TXP Medical】
TXP Medical has developed the emergency medicine information system “NEXT Stage ER” based on the mission of “save lives with medical data.” It has been introduced in 69 hospitals nationwide (as of August 31, 2023). TXP Medical will most likely be able to access nearly 40% of these hospitals to use its medical record data for clinical research and clinical trials by March 2024. These hospitals are the top-tier segment of hospitals, with an average of over 700 beds. In addition, a DWH (Data Warehouse) has been built within the hospitals to organize and store large volumes of data in chronological order, making it immediately available for data analysis.

【How we ally】
Specifically, through the business alliance, the two companies intend to make joint proposals to provide new value to client companies in the area of medical data utilization, as well as to propose more efficient operations for clinical trials by utilizing the resources of both companies. “This medical DB model, which leverages the strengths of MDV and TXP Medical, is the only and ultimate solution for DB research,” said TXP Medical’s Sonoo.